KENNETH R HESS to Radiation-Sensitizing Agents
This is a "connection" page, showing publications KENNETH R HESS has written about Radiation-Sensitizing Agents.
Connection Strength
0.037
-
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1999 Aug 01; 45(1):127-35.
Score: 0.037